Differin
®
Gel, 0.3% Before and After
Patient 1004
Patient 008
Results may vary
*A phase III, 12-week, multicenter, controlled, clinical study of patients 12 to 52 years of age with acne vulgaris of mild to moderate severity (N=653).
1
